MedTrace Logo

Visual Stimulation for Pain Relief

NCT06276881 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2024-08-07

Study results available
· View outcomes & findings →

Summary

The goal of this study is to investigate a novel neuromodulatory approach utilizing visual stimulation to impact pain perception in healthy participants.

Conditions

Interventions

BEHAVIORAL

Visual Stimulation

AI-guided visual stimuli presented on an electronic screen

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Dandelion Science

    lead INDUSTRY

Principal Investigators

  • Chief Executive Officer (CEO) · Dandelion Science Corp

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-03
Primary Completion
2022-12-28
Completion
2023-05-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06276881 on ClinicalTrials.gov